MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields

Core Insights - MiMedx Group, Inc. has launched AMNIOFIX Thyroid Shields, a product designed for use in endocrine surgery to protect the Recurrent Laryngeal Nerve and parathyroid glands during thyroidectomy procedures [1][2] Product Details - AMNIOFIX Thyroid Shields are allografts that provide a protective barrier post-thyroidectomy, supporting the healing process and preventing intraoperative modifications, thus saving time in the operating room [2] - The product is manufactured using the PURION process, is easy to apply, and has a shelf life of up to five years [2] Clinical Data - A retrospective study showed a 76% reduction in the incidence of Recurrent Laryngeal Nerve damage at 24 hours post-operation in patients who received AMNIOFIX compared to those who did not (3.4% vs. 14.4%, p<0.01) [3] Company Overview - MiMedx is a leader in providing healing solutions, focusing on chronic and hard-to-heal wounds, with a vision to be the global provider of innovative healing solutions [4]